Abiopharma

Amlan® to Present on Biotoxin Control and Antibiotic-Free Poultry Production at Malaysia Livestock 2025

New Form 6-K - SciSparc Ltd. Filed: 2025-08-25 AccNo: 0001213900-25-080337 Size: 13 KB

Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025

Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution

New Form 8-K - Nutex Health, Inc. Filed: 2025-08-25 AccNo: 0001479681-25-000070 Size: 140 KB Item 8.01: Other Events

New Form 144 - Phreesia, Inc. Filed: 2025-08-25 AccNo: 0001959173-25-005509 Size: 6 KB

Law Offices of Howard G. Smith Encourages Nutex Health Inc. (NUTX) Investors To Inquire About Securities Fraud Class Action

Gregory Dean A. 🟢 acquired 25.0K shares of CERUS CORP (CERS) at $1.25 Transaction Date: Aug 25, 2025 | Filing ID: 111175

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Stelmakh Edward 🟢 acquired 50.8K shares (1 derivative) of OptimizeRx Corp (OPRX) at $16.14 Transaction Date: Aug 21, 2025 | Filing ID: 041110

New Form 144 - Twist Bioscience Corp Filed: 2025-08-25 AccNo: 0001959173-25-005508 Size: 6 KB

Greco Theresa 🟢 acquired 50.8K shares (1 derivative) of OptimizeRx Corp (OPRX) at $16.14 Transaction Date: Aug 21, 2025 | Filing ID: 041109

Besch Doug 🟢 acquired 50.8K shares (1 derivative) of OptimizeRx Corp (OPRX) at $16.14 Transaction Date: Aug 21, 2025 | Filing ID: 041108

New Form 8-K - MESA LABORATORIES INC /CO/ Filed: 2025-08-25 AccNo: 0001437749-25-027659 Size: 195 KB Item 5.07: Submission of Matters to a Vote of Security Holders

Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO